Intraabdominal infections Flashcards
Stomach commonly found bacteria
Streptococcus, Lactobacillus
Biliary tract commonly found bacteria
Normally sterile (E. coli, Klebsiella, or enterococci in patient >70 years, acute cholecystisis, jaundice, or common bile duct stones)
Proximal small bowel commonly found organisms
Streptococcus, (including enterococci), E. coli, klebsiella, Lactobacillus, diphtheroids
Distal Ileum commonly found organisms
E. coli, Klebsiella, Enterobacter, Bacteroides fragilis, Clostridium, peptostreptococci
Colon commonly found organisms
Bacteroides spp., peptostreptococci, Clostridium, E. coli, Klebsiella, enterococci, Enterobacter, etc…
Primary peritonitis classification
infections where the GI tract integrity has NOT been comprimised
Secondary peritonitis classification
infection where the GI tract HAS been perferated
Tertiary peritonitis classification
secondary infections that fail to respond to therapy
CAPD
Chronic ambulatory peritoneal dyaliss - migration of organisms up the catheter
SBP
Spontaneous bacterial peritonitis - translocation from the bloodstream (hematogenous); impared host defenses (ascitic fluid, shunting of blood around liver) (cirrhosis)
CAPD organisms
S. aureus (most common), Pseudomonas, Streptococci
SBP organisms
E. coli (most common), Klebsiella, S. Pneumoniae
CAPD symptoms
mild symptoms, cloudy effluent
SBP symptoms
altered mental status, already have liver disease
CAPD diagnosis
> 50% PMNs/mm3
SBP diagnosis
> /= 250 PMNs/m3
secondary infections
- fever
- pain
- decreased bowel sounds
- shock
CAPD drugs
gram + (cafazolin or Vanc) + gram - coverage (AG, caftazidime, carbapenem, cipro, levo). Can use intraperitoneal ABX
SBP drugs
- cefotaxime, ceftriaxone, flouroquinolones
2. secondary SBP prophylaxis - flouroquinolone or TMP/SMX
secondary community acquired organisms (mild to moderate)
gram -, streptococci, and anaerobes
secondary community acquired high risk, or healthcare acquired organisms
broaden to cover pseudomonas
secondary community acquired drugs(mild to moderate)
- Single agents - ticaricillin/clavulanate, cofoxitin, ertapenem
- combo - metronydazole + cephalosporins OR quinolones
secondary community acquired high risk, or healthcare acquired drugs
- single agent - antipseudomonal carbapenems, PIP/TAZO
2. combo - cefepime, ceftazidime, cipro or levo + metronidazole